Federal IDR outcomes: Laboratory and pathology in Florida
In 2025 Q1–Q4, the provider or facility offer prevailed in 91.3% of 665 determined Federal IDR dispute line items for laboratory and pathology in Florida. The median prevailing offer was 1.00x the QPA (25th–75th percentile 1.00x–1.00x; n = 539). The median time to a decision was 55 business days (n = 665).
Determined line items
665
2025 Q1–Q4 · 0 split decisions excluded
Provider win rate
91.3%
n = 665 · 2025 Q1–Q4
Median payment vs QPA
1.00x
middle half 1.00x–1.00x · n = 539 · 2025 Q1–Q4
Median days to decision
55
business days, from dispute initiation · n = 665 · 2025 Q1–Q4
Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.
By period
| Period | Line items | Win % | Median ×QPA | 25th–75th | Ratio n | Median days |
|---|---|---|---|---|---|---|
| 2025 Q1–Q4 | 665 | 91.3% | 1.00x | 1.00x–1.00x | 539 | 55 |
| 2024 Q1–Q4 | 414 | 58.7% | 0.97x | 0.00x–1.00x | 411 | 124 |
| 2023 Q1–Q4 | Fewer than 30 determined line items; not shown. | |||||
| 2023 Q1–2025 Q4 | 1,083 | 78.9% | 1.00x | 0.97x–1.00x | 954 | not pooled |
Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.
Most disputed CPT codes
| CPT code | Line items | Win % | Median ×QPA | Ratio n | Median days |
|---|---|---|---|---|---|
| 81420 Test for detecting genes associated with fetal disease, aneuploidy genomic seque | 383 | 90.3% | 1.00x | 381 | 78 |
| 80307 Testing for presence of drug, by chemistry analyzers | 62 | 100.0% | – | 0 | 33 |
| 81329 Gene analysis (survival of motor neuron 1, telomeric) for dosage/deletion | 49 | 91.8% | 1.00x | 49 | 96 |
| 81220 Gene analysis (cystic fibrosis transmembrane conductance regular) common variant | 37 | 89.2% | 1.00x | 37 | 42 |
2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.
Related: all specialties in Florida · Laboratory and pathology in all states
FAQ
What is the Federal IDR provider win rate for laboratory and pathology in Florida?
In 2025 Q1–Q4, the provider or facility offer was selected in 91.3% of 665 determined dispute line items for laboratory and pathology in Florida. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.
How do Federal IDR payments compare with the QPA for laboratory and pathology in Florida?
In 2025 Q1–Q4, the median prevailing offer was 1.00x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 1.00x to 1.00x (n = 539 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.
How long do Federal IDR decisions take for laboratory and pathology in Florida?
In 2025 Q1–Q4, the median was 55 business days (n = 665 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).